- Home
- Contractors
- Idt Biologika GMBH
Idt Biologika GMBH government contracts
$11.9M obligated across 5 federal awards. 1 is still running.
Who buys from Idt Biologika GMBH
| Agency | Awards | Obligated |
|---|---|---|
| National Institutes of Health | 5 | $11.9M |
What Idt Biologika GMBH sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology) NAICS 541714 | 5 | $11.9M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
None of Idt Biologika GMBH's awards in our records end in the next 18 months.
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
| Award | Obligated | Start | End |
|---|---|---|---|
| MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2. National Institutes of Health · 75N93023F00001 | $4.2M | Sep 26, 2023 | May 14, 2028 |
| 1800011I IDT BIOLOGIKA VACCINE MANUFACTURING AND CHARACTERIZATION SERVICES TO VM19V8RDB--3 QUANTITY BASE AWARD IID CAN 8470036 $367,000.00 National Institutes of Health · 75N93019F00311 | $2.7M | Aug 19, 2019 | Apr 18, 2025 |
| HHSN272201800011I IDT BIOLOGIKA MASTER CELL BANKS MANUFACTURING FOR NEXT GENERATION SARS-COV-2 VACCINES National Institutes of Health · 75N93024F00001 | $2.6M | May 15, 2018 | Apr 18, 2025 |
| CONTRACT #HHSN272201800011I IDT BIOLOGIKA DEVELOPMENT AND MANUFACTURE OF TOXOID FUSION 3XSTAN12SMNLTR192GL211A AND CF,I,II,IV MASTER BANKS CAN 8470038 TOTAL $555,600.00 National Institutes of Health · 75N93020F00003 | $1.2M | Sep 17, 2020 | Apr 30, 2024 |
| CONTRACT #HHSN272201800011I IDT BIOLOGIKA FY21 PROCESS DEVELOPMENT AND MASTER BANK PRODUCTION FOR A STAPH AUREUS, SPA National Institutes of Health · 75N93021F00001 | $1.1M | Aug 19, 2021 | Apr 18, 2025 |
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| Advanced Technology International UEI LDMMF472BB93 | 8 | $3.5B |
| Albert B. Sabin Vaccine Institute, Inc. (The) UEI H5E8NU6N2HZ5 | 3 | $572M |
| Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28 | 4 | $398M |
| Icon Government and Public Health Solutions, Inc. UEI JHJ7HXD5XR47 | 6 | $393M |
| Technical Resources International, Inc. UEI FAA2LVENETH4 | 6 | $384M |
| Allucent Government Services (US) LLC UEI C7DJDL6EZT94 | 4 | $384M |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Idt Biologika GMBH's UEI?
E14GD5J873N9. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Idt Biologika GMBH won in federal contracts?
$11.9M obligated across 5 awards in Captivaq's records, most of it from National Institutes of Health. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Idt Biologika GMBH contracts end soon?
None of its awards in our records end in the next 18 months.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.